At the news
? NEUTRALIMPACT 3/10 S-3ASR filed Nov 9, 2026 at 17:00 ET
Immunome filed an automatic shelf registration (S-3ASR) as a well-known seasoned issuer, including an ATM sales agreement prospectus for up to $134.1 million of common stock through TD Cowen. The company had $461.6 million in cash and securities as of September 30, 2026, with a cash runway into 2028, suggesting this is an opportunistic shelf filing rather than a distress-driven capital raise.
- S-3ASR filed as a well-known seasoned issuer with no limit on aggregate securities offered under the base prospectus
- ATM sales agreement prospectus for up to $134.1 million of common stock through TD Cowen
- Prior ATM agreement had $200M authorization; $65.9M in gross proceeds raised from 6,655,587 shares sold under prior ATM
- Cash and securities totaled $461.6M as of September 30, 2026, down from $582.7M at Q1 end
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access